Abstract
Objectives: Identification of the most influential scientific publications and directions of mainstream reirradiation research. Methods: A systematic search of the database Scopus (Elsevier B.V., www.scopus.com) was performed, which focused on the time period 1998-2010. Patterns of citation were analysed (total number of citations accumulated independently of their origin and proportion of highly cited articles, arbitrarily defined as those with ≥50 citations). Results: Up to 64 articles were published each year. Numbers increased over time, especially after the year 2007. Among all 76 articles with at least 50 citations, 28 (37%) focused on head and neck cancer, 27 (36%) on brain tumours including metastases, and 5 (7%) on bone metastases. Most articles evaluated external beam approaches while 10 (13%) focused on brachytherapy. Many of the often quoted publications reported on stereotactic and/or intensity-modulated radiotherapy. Two (3%) reported on randomised clinical studies and 10 (13%) on non-randomised prospective clinical studies (single institution or cooperative group). Only two articles (3%) reported on experimental animal studies. Conclusions: The number of published reirradiation studies has increased in recent years. Many studies examined highly conformal and precise radiotherapy, in particular of brain and head and neck tumours. Given that few randomised clinical trials were published, efforts to increase this type of research activity are warranted.
Keywords: Radiotherapy, radiation oncology, radiation retreatment, reirradiation, citation, research evaluation
Introduction
For several decades, radiation oncologists have administered a repeat course of radiotherapy to a previously irradiated volume (reirradiation) in selected patients because such treatment might provide worthwhile clinical benefit in terms of palliation or sometimes even cure to patients who develop locoregional relapse or second primary tumours [1-3]. A previous audit showed that 10% of all palliative radiotherapy courses in a Norwegian health care region consisted of reirradiation [4]. Given the potentially serious consequences of normal tissue damage from high cumulative doses, intense research activity is directed towards harnessing highly conformal reirradiation techniques [5,6]. The purpose of our study was to identify the most influential scientific publications and directions of mainstream reirradiation research. For several reasons including but not limited to tenure track or likelihood of future funding, researchers attempt to publish their results in a way that ensures high visibility and allows for broad adoption of the progress achieved. Successful publication might be defined by various measures. Impact factor of journals is a two-edged sword, e.g. regarding the publication bias that strikes negative or inconclusive studies [7-9]. Article download rates might provide some indication for visibility and impact, but will depend on presence and quantity of fees charged by the publisher. Another potential measure of quality and impact of research is the citation rate [10,11]. Landmark or practice-changing research is likely to be cited by successor trials, editorials and review articles. For the purpose of this review, we focused mainly on citation rates of articles published between 1998 and 2010. Information about highly cited article types can be useful for preparation of future research projects. Moreover, identification of underrepresented areas might facilitate efforts to increase their visibility.
Methods
A systematic search of the database Scopus (Elsevier B.V., www.scopus.com) by use of the key words ‘reirradiation’, ‘re-irradiation’, ‘repeat radiotherapy’, ‘radiation retreatment’ and ‘recurrent AND radiotherapy’ was performed on 3th September 2012. Articles were selected irrespective of language and article type (review, clinical study, experimental study etc.). Patterns of citation (field ‘times cited’ in the Scopus citation database) were analysed as described in a previous study [12]. We evaluated total number of citations accumulated independently of their origin, and proportion of highly cited articles, arbitrarily defined as those with ≥50 citations. A complete list of articles cited at least 50 times can be requested from the corresponding author. While focusing on the time period 1998-2010, both younger and older publications were included for selected end points.
Results
Up to 64 articles were published each year. Figure 1 shows the number of publications per year, which has increased over time (especially after the year 2007). References [13-51] represent the 3 most frequently cited articles per year. After 2008, more and more of these often quoted studies reported on highly conformal irradiation techniques such as stereotactic and frameless robotic radiotherapy [13,15,16,18]. However, it becomes clear from earlier studies that new technological developments always were utilised for the purpose of reirradiation early after commercial availability [44,52]. Experimental technology such as carbon ion radiotherapy or boron neutron capture therapy also was harnessed [31,32,35]. Many studies incorporated strategies of radiosensitisation, e.g. by chemotherapy [23,27,40,41], which in theory might broaden the therapeutic window of reirradiation. Table 1 shows the 10 most frequently cited articles overall. Most of these were clinical studies related to head and neck or brain tumours. All of them were published before 2005. Since articles published for example in 2000 are more likely to have accumulated a large number of citations than articles published in 2010, the average of the annual numbers of citations was also calculated. For this purpose, 2012 was defined as 0.67 years (January 01st - September 02nd). Table 2 shows the 10 articles with most citations per year (in fact 12 articles because some had equal citation counts). The table contains articles published between 2000 and 2009. This distribution suggests that citation of older articles declines after 10-12 years. Again, most of the articles were clinical studies related to head and neck or brain tumours. Many of them reported on stereotactic and/or intensity-modulated radiotherapy.
Table 1.
Authors and year of publication | Short title | Absolute citation count | Citations per year |
---|---|---|---|
Shaw et al. 2000 [43] | RTOG 90-05 radiosurgery study | 312 | 27 |
Schulz-Ertner et al. 2004 [31] | Carbon ion radiotherapy | 149 | 19 |
Chao et al. 2000 [44] | IMRT for head and neck cancer | 144 | 12 |
De Crevoisier et al. 1998 [49] | Head and neck cancer | 136 | 10 |
Loeffler et al. 1990 [52] | Radiosurgery for brain metastases | 135 | 6 |
Catton et al. 1996 [53] | Chordoma | 133 | 8 |
Castro et al. 1994 [54] | Charged particle skull base irradiation | 133 | 8 |
Wang 1987 [55] | Nasopharynx cancer | 133 | 5 |
Grado et al. 1999 [46] | Prostate cancer brachytherapy | 127 | 10 |
Lee et al. 1993 [56] | Nasopharynx cancer | 119 | 6 |
RTOG: Radiation Therapy Oncology Group, IMRT: intensity modulated radiotherapy.
Table 2.
Authors and year of publication | Short title | Citations per year | Absolute citation count |
---|---|---|---|
Gutin et al. 2009 [16] | SFRT for glioma | 31 | 83 |
Shaw et al. 2000 [43] | RTOG 90-05 radiosurgery study | 27 | 312 |
Iwamoto et al. 2009 [17] | Glioblastoma | 26 | 70 |
Maier-Hauff et al. 2007 [22] | Glioblastoma | 24 | 111 |
Schulz-Ertner et al. 2004 [31] | Carbon ion radiotherapy | 19 | 149 |
Grosu et al. 2005 [28] | SFRT for glioma | 17 | 112 |
Sterzing et al. 2008 [19] | Helical tomotherapy | 17 | 64 |
Seiwert et al. 2008 [20] | Head and neck cancer | 17 | 61 |
Sulman et al. 2009 [18] | IMRT for head and neck cancer | 17 | 46 |
Salama et al. 2006 [25] | Head and neck cancer | 14 | 77 |
Janot et al. 2008 [21] | Head and neck cancer | 14 | 52 |
Sahgal et al. 2009 [57] | SBRT for spinal metastases | 14 | 38 |
SFRT: stereotactic fractionated radiotherapy, RTOG: Radiation Therapy Oncology Group, IMRT: intensity modulated radiotherapy, SBRT: stereotactic body radiotherapy.
As shown in Figure 1, variable numbers of articles acquired at least 50 citations. With one exception (the year 2000 where 42% of all articles were cited at least 50 times) less than one third of articles were cited at least 50 times. Among all 76 articles with at least 50 citations (1998-2010), 28 (37%) focused on head and neck cancer, 27 (36%) on brain tumours including metastases, and 5 (7%) on bone metastases. Other types of cancer were represented less frequently. Most articles evaluated external beam approaches while 10 (13%) focused on brachytherapy. Only two articles (3%) reported on experimental animal studies [42,58], and one (1%) was a review paper [59]. Two (3%) reported on randomised clinical studies [21,60], and 10 (13%) on non-randomised prospective clinical studies (single institution or cooperative group). These 76 articles were published in 15 different scientific journals. Twenty articles (26%) were published in the International Journal of Radiation Oncology Biology and Physics, 5 (7%) in the Journal of Clinical Oncology, 4 (5%) in Cancer, and 2 each (3%) in Radiotherapy and Oncology, Neurosurgery, Journal of Neurosurgery and Journal of Neuro-Oncology.
Discussion
The objective of this review was to identify influential, highly cited scientific publications and thereby research mainstreams related to reirradiation. After arbitrary decisions about which database to search and which keywords to use, we performed a systematic literature search and applied a broad definition of reirradiation related publication. For example, articles which reported on salvage treatment of a certain type of cancer where subgroups received reirradiation were included. Citation rate of published articles was evaluated. Articles with high numbers of citations are likely those that impressed other clinicians/scientists and had profound influence on clinical practice or future developments in the field. Besides absolute number of citations, we also evaluated average annual citation rate because the exact time course or kinetics of citation is hard to predict and varies with topic and journal [61]. Both accumulation of citations of recently published articles and reduced interest in older articles over time pose challenges if reliable quantitative analysis is attempted. We did not account for date of publication, i.e. whether an article was published earlier or later during a given year. For the purpose of this overview, the chosen methods are sufficient even if more detailed and quantitative analyses can be performed with the internet based tools available. It should be noticed that searches in different databases or with different key words will result in more or less variable citation counts and that the present results therefore provide only a snapshot. Self citation is likely to influence the final citation count of sparsely cited articles, whereas its impact on highly cited articles might be less pronounced. It was recently estimated that 6.4% of all citations per article (interquartile range 2.8–11.3, mean 8.4) were self citations [62]. Studies most vulnerable to this effect were those with more authors and small sample size.
Reirradiation research activity has increased in the time period studied here. Our results are consistent with the assumption that citation rate is gradually increasing for several years after publication. However, the purpose of this overview was not to explore dynamics of citation count. Given the fact that most scientific radiation oncology journals had steady increases in the number of published issues and articles, and that each article contains a certain number of references, the increase in total numbers of publications over time is expected to lead to a parallel increase in citation rates. It is also interesting to note that highly cited research was published in a large number of different scientific journals with or without high impact factor, but always in the English language.
During the time period between 1998 and 2010, major progress has been achieved in the areas of combined modality treatment and implementation of highly conformal radiotherapy techniques. Several articles on these subjects were among those with the highest numbers of citations. Despite overrepresentation of head and neck and brain tumour studies, reirradiation is administered to targets throughout the body [34,37,39,46]. The small number of published randomised clinical trials is noteworthy. In order to establish regimens, which are based on the highest level of evidence, more randomised studies and metaanalyses are necessary. In contrast to general radiation oncology publications [63], reirradiation studies did not achieve more than 40 citations per year (average number). Given that randomised trials and metaanalyses are the most frequently cited study types [10,63] their scarcity explains the observed difference in citation pattern. The limited preclinical research activity during recent years [42,58], addressing for example reirradiation tolerance of normal tissues, was also surprising. Prospective clinical research in related areas of toxicity prevention and mitigation by use of radioprotectors and response modifiers was not among the highly cited studies reviewed here. Efforts to support randomised prospective trials and normal tissue research might be warranted.
Conclusions
The number of published reirradiation studies has increased in recent years. Many studies examined highly conformal and precise radiotherapy and combined modality treatment, in particular of brain and head and neck tumours. Few randomised clinical trials were published.
References
- 1.Skołyszewski J, Korzeniowski S, Reinfuss M. The reirradiation of recurrences of head and neck cancer. Br J Radiol. 1980;53:462–465. doi: 10.1259/0007-1285-53-629-462. [DOI] [PubMed] [Google Scholar]
- 2.Dritschilo A, Bruckman JE, Cassady JR, Belli JA. Tolerance of brain to multiple courses of radiation therapy. I. Clinical experiences. Br J Radiol. 1981;54:782–786. doi: 10.1259/0007-1285-54-645-782. [DOI] [PubMed] [Google Scholar]
- 3.Lee AW, Law SC, Ng SH, Chan DK, Poon YF, Foo W, Tung SY, Cheung FK, Ho JH. Retrospective analysis of nasopharyngeal carcinoma treated during 1976-1985: late complications following megavoltage irradiation. Br J Radiol. 1992;65:918–928. doi: 10.1259/0007-1285-65-778-918. [DOI] [PubMed] [Google Scholar]
- 4.Nieder C, Pawinski A, Haukland E, Dokmo R, Phillipi I, Dalhaug A. Estimating need for palliative external beam radiotherapy in adult cancer patients. Int J Radiat Oncol Biol Phys. 2010;76:207–211. doi: 10.1016/j.ijrobp.2009.01.028. [DOI] [PubMed] [Google Scholar]
- 5.Manikandan A, Sarkar B, Holla R, Vivek TR, Sujatha N. Quality assurance of dynamic parameters in volumetric modulated arc therapy. Br J Radiol. 2012;85:1002–1010. doi: 10.1259/bjr/19152959. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Richmond ND, Pilling KE, Peedell C, Shakespeare D, Walker CP. Positioning accuracy for lung stereotactic body radiotherapy patients determined by on-treatment cone-beam CT imaging. Br J Radiol. 2012;85:819–823. doi: 10.1259/bjr/54341099. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Young NS, Ioannidis JPA, Al-Ubaydli O. Why current publication practices may distort science. PLoS Med. 2008;5:e201. doi: 10.1371/journal.pmed.0050201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Kanaan Z, Galandiuk S, Abby M, Shannon KV, Dajani D, Hicks N, Rai SN. The value of lesser-impact-factor surgical journals as a source of negative and inconclusive outcomes reporting. Ann Surg. 2011;253:619–623. doi: 10.1097/SLA.0b013e31820d9b04. [DOI] [PubMed] [Google Scholar]
- 9.Durieux V, Gevenois PA. Bibliometric indicators: quality measurements of scientific publication. Radiology. 2010;255:342–351. doi: 10.1148/radiol.09090626. [DOI] [PubMed] [Google Scholar]
- 10.Radicchi F, Fortunato S, Castellano C. Universality of citation distributions: toward an objective measure of scientific impact. Proc Natl Acad Sci USA. 2008;105:17268–17272. doi: 10.1073/pnas.0806977105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Vinkler P. Relations of relative scientometric indicators. Scientometrics. 2003;58:687–694. [Google Scholar]
- 12.Nieder C, Astner ST, Grosu AL. Glioblastoma research 2006-2010: Pattern of citation and systematic review of highly cited articles. Clin Neurol Neurosurg. 2012;114:1207–1210. doi: 10.1016/j.clineuro.2012.03.049. [DOI] [PubMed] [Google Scholar]
- 13.Fogh SE, Andrews DW, Glass J, Curran W, Glass C, Champ C, Evans JJ, Hyslop T, Pequignot E, Downes B, Comber E, Maltenfort M, Dicker AP, Werner-Wasik M. Hypofractionated stereotactic radiation therapy: An effective therapy for recurrent high-grade gliomas. J. Clin. Oncol. 2010;28:3048–3053. doi: 10.1200/JCO.2009.25.6941. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Ammirati M, Cobbs CS, Linskey ME, Paleologos NA, Ryken TC, Burri SH, Asher AL, Loeffler JS, Robinson PD, Andrews DW, Gaspar LE, Kondziolka D, McDermott M, Mehta MP, Mikkelsen T, Olson JJ, Patchell RA, Kalkanis SN. The role of retreatment in the management of recurrent/progressive brain metastases: A systematic review and evidence-based clinical practice guideline. J Neurooncol. 2010;96:85–96. doi: 10.1007/s11060-009-0055-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Unger KR, Lominska CE, Deeken JF, Davidson BJ, Newkirk KA, Gagnon GJ. Fractionated stereotactic radiosurgery for reirradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2010;77:1411–1419. doi: 10.1016/j.ijrobp.2009.06.070. [DOI] [PubMed] [Google Scholar]
- 16.Gutin PH, Iwamoto FM, Beal K, Mohile NA, Karimi S, Hou BL. Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas. Int J Radiat Oncol Biol Phys. 2009;75:156–163. doi: 10.1016/j.ijrobp.2008.10.043. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Iwamoto FM, Abrey LE, Beal K, Gutin PH, Rosenblum MK, Reuter VE. Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma. Neurology. 2009;73:1200–1206. doi: 10.1212/WNL.0b013e3181bc0184. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Sulman EP, Schwartz DL, Le TT, Ang KK, Morrison WH, Rosenthal DI. IMRT reirradiation of head and neck cancer - Disease control and morbidity outcomes. Int J Radiat Oncol Biol Phys. 2009;73:399–409. doi: 10.1016/j.ijrobp.2008.04.021. [DOI] [PubMed] [Google Scholar]
- 19.Sterzing F, Schubert K, Sroka-Perez G, Kalz J, Debus J, Herfarth K. Helical tomotherapy: Experiences of the first 150 patients in Heidelberg. Strahlenther Onkol. 2008;184:8–14. doi: 10.1007/s00066-008-1778-6. [DOI] [PubMed] [Google Scholar]
- 20.Seiwert TY, Haraf DJ, Cohen EE, Stenson K, Witt ME, Dekker A. Phase I study of bevacizumab added to fluorouracil- and hydroxyurea-based concomitant chemoradiotherapy for poor-prognosis head and neck cancer. J. Clin. Oncol. 2008;26:1732–1741. doi: 10.1200/JCO.2007.13.1706. [DOI] [PubMed] [Google Scholar]
- 21.Janot F, De Raucourt D, Benhamou E, Ferron C, Dolivet G, Bensadoun RJ. Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma. J. Clin. Oncol. 2008;26:5518–5523. doi: 10.1200/JCO.2007.15.0102. [DOI] [PubMed] [Google Scholar]
- 22.Maier-Hauff K, Rothe R, Scholz R, Gneveckow U, Wust P, Thiesen B. Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: Results of a feasibility study on patients with glioblastoma multiforme. J Neurooncol. 2007;81:53–60. doi: 10.1007/s11060-006-9195-0. [DOI] [PubMed] [Google Scholar]
- 23.Langer CJ, Harris J, Horwitz EM, Nicolaou N, Kies M, Curran W. Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: Results of Radiation Therapy Oncology Group protocol 9911. J. Clin. Oncol. 2007;25:4800–4805. doi: 10.1200/JCO.2006.07.9194. [DOI] [PubMed] [Google Scholar]
- 24.Lee N, Chan K, Bekelman JE, Zhung J, Mechalakos J, Narayana A. Salvage re-irradiation for recurrent head and neck cancer. Int J Radiat Oncol Biol Phys. 2007;68:731–740. doi: 10.1016/j.ijrobp.2006.12.055. [DOI] [PubMed] [Google Scholar]
- 25.Salama JK, Vokes EE, Chmura SJ, Milano MT, Kao J, Stenson KM. Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2006;64:382–391. doi: 10.1016/j.ijrobp.2005.07.005. [DOI] [PubMed] [Google Scholar]
- 26.Gabayan AJ, Green SB, Sanan A, Jenrette J, Schultz C, Papagikos M. GliaSite brachytherapy for treatment of recurrent malignant gliomas: A retrospective multi-institutional analysis. Neurosurgery. 2006;58:701–708. doi: 10.1227/01.NEU.0000194836.07848.69. [DOI] [PubMed] [Google Scholar]
- 27.Wong SJ, Machtay M, Li Y. Locally recurrent, previously irradiated head and neck cancer: Concurrent re-irradiation and chemotherapy, or chemotherapy alone? J. Clin. Oncol. 2006;24:2653–2658. doi: 10.1200/JCO.2005.05.3850. [DOI] [PubMed] [Google Scholar]
- 28.Grosu AL, Weber WA, Franz M, Stark S, Piert M, Thamm R, Molls M, Nieder C. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. Int J Radiat Oncol Biol Phys. 2005;63:511–519. doi: 10.1016/j.ijrobp.2005.01.056. [DOI] [PubMed] [Google Scholar]
- 29.Van Waes C, Chang AA, Lebowitz PF, Druzgal CH, Chen Z, Elsayed YA. Inhibition of nuclear factor-κB and target genes during combined therapy with proteasome inhibitor bortezomib and reirradiation in patients with recurrent head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2005;63:1400–1412. doi: 10.1016/j.ijrobp.2005.05.007. [DOI] [PubMed] [Google Scholar]
- 30.Combs SE, Widmer V, Thilmann C, Hof H, Debus J, Schulz-Ertner D. Stereotactic radiosurgery (SRS): Treatment option for recurrent glioblastoma multiforme (GBM) Cancer. 2005;104:2168–2173. doi: 10.1002/cncr.21429. [DOI] [PubMed] [Google Scholar]
- 31.Schulz-Ertner D, Nikoghosyan A, Thilmann C, Haberer T, Jakel O, Karger C. Results of carbon ion radiotherapy in 152 patients. Int J Radiat Oncol Biol Phys. 2004;58:631–640. doi: 10.1016/j.ijrobp.2003.09.041. [DOI] [PubMed] [Google Scholar]
- 32.Kato I, Ono K, Sakurai Y, Ohmae M, Maruhashi A, Imahori Y. Effectiveness of BNCT for recurrent head and neck malignancies. Appl Radiat Isot. 2004;61:1069–1073. doi: 10.1016/j.apradiso.2004.05.059. [DOI] [PubMed] [Google Scholar]
- 33.Lu TX, Mai WY, Teh BS, Zhao C, Han F, Huang Y. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2004;58:682–687. doi: 10.1016/S0360-3016(03)01508-6. [DOI] [PubMed] [Google Scholar]
- 34.Milker-Zabel S, Zabel A, Thilmann C, Schlegel W, Wannenmacher M, Debus J. Clinical results of retreatment of vertebral bone metastases by stereotactic conformal radiotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2003;55:162–167. doi: 10.1016/s0360-3016(02)03864-6. [DOI] [PubMed] [Google Scholar]
- 35.Joensuu H, Kankaanranta L, Seppala T, Auterinen I, Kallio M, Kulvik M. Boron neutron capture therapy of brain tumors: Clinical trials at the Finnish facility using boronophenylalanine. J Neurooncol. 2003;62:123–134. doi: 10.1007/BF02699939. [DOI] [PubMed] [Google Scholar]
- 36.Tatter SB, Shaw EG, Rosenblum ML, Karvelis KC, Kleinberg L, Weingart J. An inflatable balloon catheter and liquid 125I radiation source (GliaSite Radiation Therapy System) for treatment of recurrent malignant glioma: Multicenter safety and feasibility trial. J Neurosurg. 2003;99:297–303. doi: 10.3171/jns.2003.99.2.0297. [DOI] [PubMed] [Google Scholar]
- 37.Mohiuddin M, Marks G, Marks J. Long-term results of reirradiation for patients with recurrent rectal carcinoma. Cancer. 2002;95:1144–1150. doi: 10.1002/cncr.10799. [DOI] [PubMed] [Google Scholar]
- 38.Larson DA, Prados M, Lamborn KR, Smith V, Sneed PK, Chang S. Phase II study of high central dose Gamma Knife radiosurgery and marimastat in patients with recurrent malignant glioma. Int J Radiat Oncol Biol Phys. 2002;54:1397–1404. doi: 10.1016/s0360-3016(02)03743-4. [DOI] [PubMed] [Google Scholar]
- 39.Deutsch M. Repeat high-dose external beam irradiation for in-breast tumor recurrence after previous lumpectomy and whole breast irradiation. Int J Radiat Oncol Biol Phys. 2002;53:687–691. doi: 10.1016/s0360-3016(02)02785-2. [DOI] [PubMed] [Google Scholar]
- 40.Spencer SA, Harris J, Wheeler RH, Machtay M, Schultz C, Spanos W. RTOG 96-10: Reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck. Int J Radiat Oncol Biol Phys. 2001;51:1299–1304. doi: 10.1016/s0360-3016(01)01745-x. [DOI] [PubMed] [Google Scholar]
- 41.De Crevoisier R, Domenge C, Wibault P, Koscielny S, Lusinchi A, Janot F. Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma. Cancer. 2001;91:2071–2076. doi: 10.1002/1097-0142(20010601)91:11<2071::aid-cncr1234>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
- 42.Ang KK, Jiang GL, Feng Y, Stephens LC, Tucker SL, Price RE. Extent and kinetics of recovery of occult spinal cord injury. Int J Radiat Oncol Biol Phys. 2001;50:1013–1020. doi: 10.1016/s0360-3016(01)01599-1. [DOI] [PubMed] [Google Scholar]
- 43.Shaw E, Scott C, Souhami L, Dinapoli R, Kline R, Loeffler J. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: Final report of RTOG protocol 90- 05. Int J Radiat Oncol Biol Phys. 2000;47:291–298. doi: 10.1016/s0360-3016(99)00507-6. [DOI] [PubMed] [Google Scholar]
- 44.Chao KS, Low DA, Perez CA, Purdy JA. Intensity-modulated radiation therapy in head and neck cancers: The Mallinckrodt Experience. Int J Cancer. 2000;90:92–103. doi: 10.1002/(sici)1097-0215(20000420)90:2<92::aid-ijc5>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
- 45.Schwartz GJ, Mehta RH, Wenig BL, Shaligram C, Portugal LG. Salvage treatment for recurrent squamous cell carcinoma of the oral cavity. Head Neck. 2000;22:34–41. doi: 10.1002/(sici)1097-0347(200001)22:1<34::aid-hed6>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
- 46.Grado GL, Collins JM, Kriegshauser JS, Balch CS, Grado MM, Swanson GP. Salvage brachytherapy for localized prostate cancer after radiotherapy failure. Urology. 1999;53:2–10. doi: 10.1016/s0090-4295(98)00492-0. [DOI] [PubMed] [Google Scholar]
- 47.Cho KH, Hall WA, Gerbi BJ, Higgins PD, McGuire WA, Clark HB. Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas. Int J Radiat Oncol Biol Phys. 1999;45:1133–1141. doi: 10.1016/s0360-3016(99)00336-3. [DOI] [PubMed] [Google Scholar]
- 48.Hudes RS, Corn BW, Werner-Wasik M, Andrews D, Rosenstock J, Thoron L. A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma. Int J Radiat Oncol Biol Phys. 1999;43:293–298. doi: 10.1016/s0360-3016(98)00416-7. [DOI] [PubMed] [Google Scholar]
- 49.De Crevoisier R, Bourhis J, Domenge C, Wibault P, Koscielny S, Lusinchi A. Full-dose reirradiation for unresectable head and neck carcinoma: Experience at the Gustave-Roussy Institute in a series of 169 patients. J. Clin. Oncol. 1998;16:3556–3562. doi: 10.1200/JCO.1998.16.11.3556. [DOI] [PubMed] [Google Scholar]
- 50.Teo PM, Kwan WH, Chan AT, Lee WY, King WW, Mok CO. How successful is high-dose ( 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma? Int J Radiat Oncol Biol Phys. 1998;40:897–913. doi: 10.1016/s0360-3016(97)00854-7. [DOI] [PubMed] [Google Scholar]
- 51.Chua DT, Sham JS, Kwong DL, Wei WI, Au GK, Choy D. Locally recurrent nasopharyngeal carcinoma: Treatment results for patients with computed tomography assessment. Int J Radiat Oncol Biol Phys. 1998;41:379–386. doi: 10.1016/s0360-3016(98)00063-7. [DOI] [PubMed] [Google Scholar]
- 52.Loeffler JS, Kooy HM, Wen PY, Fine HA, Cheng CW, Mannarino EG, Tsai JS, Alexander E 3rd. The treatment of recurrent brain metastases with stereotactic radiosurgery. J. Clin. Oncol. 1990;8:576–82. doi: 10.1200/JCO.1990.8.4.576. [DOI] [PubMed] [Google Scholar]
- 53.Catton C, O’Sullivan B, Bell R, Laperriere N, Cummings B, Fornasier V. Chordoma: Long-term follow-up after radical photon irradiation. Radiother Oncol. 1996;41:67–70. doi: 10.1016/s0167-8140(96)91805-8. [DOI] [PubMed] [Google Scholar]
- 54.Castro JR, Linstadt DE, Bahary JP, Petti PL, Daftari I, Collier JM. Experience in charged particle irradiation of tumors of the skull base: 1977-1992. Int J Radiat Oncol Biol Phys. 1994;29:647–655. doi: 10.1016/0360-3016(94)90550-9. [DOI] [PubMed] [Google Scholar]
- 55.Wang CC. Re-irradiation of recurrent nasopharyngeal carcinoma - treatment techniques and results. Int J Radiat Oncol Biol Phys. 1987;13:953–956. doi: 10.1016/0360-3016(87)90030-7. [DOI] [PubMed] [Google Scholar]
- 56.Lee AW, Law SC, Foo W, Poon YF, Cheung FK, Chan DK. Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976-1985: Survival after local recurrence. Int J Radiat Oncol Biol Phys. 1993;26:773–782. doi: 10.1016/0360-3016(93)90491-d. [DOI] [PubMed] [Google Scholar]
- 57.Sahgal A, Ames C, Chou D, Ma L, Huang K, Xu W, Chin C, Weinberg V, Chuang C, Weinstein P, Larson DA. Stereotactic body radiotherapy is effective salvage therapy for patients with prior radiation of spinal metastases. Int J Radiat Oncol Biol Phys. 2009;74:723–731. doi: 10.1016/j.ijrobp.2008.09.020. [DOI] [PubMed] [Google Scholar]
- 58.Ang KK, Price RE, Stephens LC, Jiang GL, Feng Y, Schultheiss TE. The tolerance of primate spinal cord to re-irradiation. Int J Radiat Oncol Biol Phys. 1993;25:459–464. doi: 10.1016/0360-3016(93)90067-6. [DOI] [PubMed] [Google Scholar]
- 59.Nieder C, Milas L, Ang KK. Tissue tolerance to reirradiation. Semin Radiat Oncol. 2000;10:200–209. doi: 10.1053/srao.2000.6593. [DOI] [PubMed] [Google Scholar]
- 60.Emami B, Scott C, Perez CA, Asbell S, Swift P, Grigsby P. Phase III study of interstitial thermoradiotherapy compared with interstitial radiotherapy alone in the treatment of recurrent or persistent human tumors: A prospectively controlled randomized study by the radiation therapy oncology group. Int J Radiat Oncol Biol Phys. 1996;34:1097–1104. doi: 10.1016/0360-3016(95)02137-x. [DOI] [PubMed] [Google Scholar]
- 61.Stringer MJ, Sales-Pardo M, Nunes Amaral LA. Statistical validation of a global model for the distribution of the ultimate number of citations accrued by papers published in a scientific journal. J Am Soc Inf Sci Technol. 2010;61:1377–1385. doi: 10.1002/asi.21335. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Kulkarni AV, Aziz B, Shams I, Busse JW. Author self-citation in the general medicine literature. PLoS One. 2011;6:e20885. doi: 10.1371/journal.pone.0020885. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Nieder C. Highly cited German research contributions to the fields of radiation oncology, biology, and physics: focus on collaboration and diversity. Strahlenther Onkol. 2012;188:865–872. doi: 10.1007/s00066-012-0154-8. [DOI] [PubMed] [Google Scholar]